インドの皮膚フィラー市場の評価：製品タイプ別、用途別、成分別、エンドユーザー別、地域別、機会、予測、2018年～2032年

インドの皮膚フィラー市場は、2025年から2032年の予測期間中にCAGR12％を記録し、2024年の1億3,146万米ドルから、2032年には3億2,549万米ドルに成長すると予測されています。

美容皮膚科学の分野では、皮膚フィラーは、下垂、小じわ、しわの外観を軽減するために、特定の皮膚領域のボリュームを上げることを目的とした注入可能な材料です。皮膚フィラーは通常コラーゲン、ヒアルロン酸、または合成物質で作られており、若々しい外観を与えることを目的としています。この非侵襲的な美容施術は、老化の兆候を治療するのに有効であるため、人気が高まっています。一般的に手術に伴う療養期間に耐えることなく、よりリフレッシュした印象を与える短期的な方法です。数多くの要因がインドの皮膚フィラー業界に大きな影響を与えています。顧客の美意識の高まりや低侵襲な施術への選好が需要の増加をもたらしています。また、より長持ちし、自然な仕上がりを保証する製品組成の改善も業界の利益となっています。さらに、人口の高齢化と支出能力の増大がアンチエイジング製品の需要を牽引しており、これも業界を牽引する要因となっています。世界中で美を向上させる施術の利用しやすさと受容性が高まっていることは、皮膚フィラー市場を安定成長の軌道に向かわせる主な要因です。

例えば、2022年8月、Allergan Aesthetics plc（AbbVie Inc.の一部）は、インドで特に顎のラインと顎のために作られたヒアルロン酸皮膚フィラーJuvederm VOLUXを発表しました。VOLUXはヒアルロン酸25mg＋塩酸リドカイン3mgの組み合わせで、特に顎と顎のラインに使用するようにデザインされています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 インドの皮膚フィラー市場の展望、2018年～2032年

• 市場規模の分析と予測
  • 金額別
  • 数量別
• 市場シェア分析と予測
  • 製品タイプ別
    • 生分解性
    • 生分解性なし
  • 用途別
    • フェイスライン矯正
    • 唇の増大
    • フェイスリフト
    • ニキビ跡の治療
    • その他
  • 材料別
    • ヒアルロン酸
    • カルシウムヒドロキシアパタイト
    • ポリ-L-乳酸
    • その他
  • エンドユーザー別
    • 専門皮膚科クリニック
    • 病院・診療所
    • その他
  • 地域別
    • 北部
    • 南部
    • 東部
    • 西部・中部
    • 企業別市場シェア分析（上位5社とその他-金額別、2024年）
• 市場マップ分析、2024年
  • 製品タイプ別
  • 用途別
  • 材料別
  • エンドユーザー別
  • 地域別

すべてのセグメントは、対象となるすべての地域と国で提供されます。

第5章 需要供給分析

第6章 バリューチェーン分析

第7章 ポーターのファイブフォース分析

第8章 PESTLE分析

第9章 価格分析

第10章 市場力学

• 市場促進要因
• 市場の課題

第11章 市場の動向と発展

第12章 規制枠組みとイノベーション

• 臨床試験（世界）
• 規制当局の承認

第13章 特許の情勢

第14章 ケーススタディ

第15章 競合情勢

• 市場リーダー上位5社の競合マトリックス
• ト上位5企業のSWOT分析
• 市場上位10の主要企業の情勢
  • Galderma SA
  • 会社概要
  • 主要経営陣
  • 製品とサービス
  • 財務状況（報告通り）
  • 主な市場フォーカスと地理的プレゼンス
  • 最近の動向/コラボレーション/パートナーシップ/合併と買収
  • Bioplus Co., Ltd.
  • Prollenium Medical Technologies Inc.
  • BIOXIS Pharmaceuticals SAS
  • Sinclair, Inc.
  • Allergan Aesthetics plc（AbbVie Inc.）
  • Dr. Korman Laboratories Ltd.
  • Zhejiang Jingjia Medical Technology Co., Ltd.
  • Medytox Inc.
  • SciVision Biotech Inc.

上記の企業は市場シェアに基づいて注文を保留しておらず、調査作業中に入手可能な情報に基づいて変更される可能性があります。

第16章 戦略的提言

第17章 調査会社について・免責事項

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Dermal Fillers Market, By Value, In USD Million, FY2018-FY2032F
• Figure 2. India Dermal Fillers Market, By Volume, In Million Units, FY2018-FY2032F
• Figure 3. India Dermal Fillers Market Share (%), By Product Type, FY2018-FY2032F
• Figure 4. India Dermal Fillers Market Share (%), By Application, FY2018-FY2032F
• Figure 5. India Dermal Fillers Market Share (%), By Ingredients, FY2018-FY2032F
• Figure 6. India Dermal Fillers Market Share (%), By End-user, FY2018-FY2032F
• Figure 7. India Dermal Fillers Market Share (%), By Region, FY2018-FY2032F
• Figure 8. By Product Type Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 9. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 10. By Ingredients Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 11. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 12. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2024

India dermal fillers market is projected to witness a CAGR of 12% during the forecast period FY2025-FY2032, growing from USD 131.46 million in FY2024 to USD 325.49 million in FY2032.

In the field of cosmetic dermatology, dermal fillers are injectable materials intended to raise the volume of certain skin regions to lessen the appearance of drooping, fine lines, and wrinkles. Dermal fillers, which are usually made of collagen, hyaluronic acid, or synthetic materials, are intended to give a youthful appearance. The efficacy of this non-invasive cosmetic procedure in treating signs of ageing has led to its increasing popularity. It gives patients a short-term way to seem more refreshed without having to endure the recuperation period typically associated with surgery. Numerous factors have a major impact on the India dermal filler industry. Customers' growing aesthetic consciousness and preference for minimally invasive procedures have led to an increase in demand. The industry also benefits from improvements in product compositions that guarantee longer-lasting and seemingly natural results. Moreover, ageing population coupled with growing expenditure capacity, has led the demand for anti-aging products, is another factor driving the industry. The increasing accessibility and acceptance of beauty-enhancing procedures around the world are major factors propelling the dermal fillers market towards a trajectory of stable growth.

For example, in August 2022, Allergan Aesthetics plc (part of AbbVie Inc.) introduced Juvederm VOLUX, a hyaluronic acid dermal filler created especially for the jawline and chin in India. VOLUX is a combination of Hyaluronic acid 25 mg + Lidocaine hydrochloride 3 mg, specifically designed for use in the chin and jawline.

Rising Consumer Awareness Boosting the Market Growth

The market for dermal fillers is expanding rapidly due to recent developments in India. Perception of cosmetic procedures is changing as a result of the growing acceptability of aesthetic treatments, especially among younger consumers. Dermal fillers have become increasingly popular as more people look for non-surgical ways to improve their faces. This trend has been aided by the growth of cosmetic clinics and medical spas in cities. Improvements in safety and efficacy brought about by technological developments in filler formulations, particularly those based on hyaluronic acid, have increased the appeal of these procedures. Furthermore, social media platforms have been playing important part in normalising cosmetic operations and persuading people that dermal fillers are a good way to improve their appearance. This tendency has been further stimulated by the growth of a middle class with more discretionary income, which enables more people to spend money on cosmetic improvements. Additionally, India's standing as a medical tourism destination is drawing in foreign patients looking for premium care at affordable costs. These elements, together with calculated partnerships between producers and clinics, are fostering a thriving dermal fillers market in India and setting it up for future growth. According to the International Society of Aesthetic Plastic Surgery data published in 2023, a total of 222,544 non-surgical injectable procedures performed in India, a significant increase from just 90,384 in 2020.

Recent Advancements to Fuel Market Growth

Advances in filler compositions, such as the advent of hyaluronic acid-based fillers with varying degrees of cross-linking, have changed the available treatment choices. Professionals can now customize their treatments to yield better, longer-lasting benefits thanks to these advancements. For instance, new biodegradable and bioresorbable fillers address sustainability concerns and appeal to environmentally conscious consumers. Additionally, the administration of dermal fillers is now more accurate and effective due to the use of advanced injectable procedures, which also shorten recovery times and minimize patient discomfort. The rise in minimally invasive procedures has further boosted demand as more people search for non-surgical options for aesthetic improvements. Furthermore, as research and development continue, projects are broadening the range of dermal filler treatments beyond conventional ones like wrinkle treatment and lip augmentation to include volume restoration and facial contouring. This continuous innovation not only drives market growth but also enhances consumer confidence in aesthetic procedures, solidifying the role of technology as a key factor in the dermal fillers market expansion. For instance, in December 2022, Gufic Biosciences Ltd. introduced a locally produced injection of botulinum toxin type A (Botox) in India. In India, Gufic Biosciences Ltd's botox will be marketed under the name "Zarbot." According to the company, one of "Zarbot's" key characteristics is that it was produced utilizing a patented method and refined strain, which leads to a thin film formulation and superior stability when compared to other botulinum toxin brands.

Influencers and Celebrities Fueling Market Growth

The market for dermal fillers in India is being driven largely by celebrities and influencers, who also have a big impact on how the general public views and accepts cosmetic operations. Prominent people who freely talk about their experiences with fillers normalize these procedures and inspire admirers to think about getting similar improvements. Their openness about their personal preferences for aesthetic changes promotes a society in which cosmetic surgery is no longer seen as taboo but rather as a way to better oneself. Fans may closely monitor the beauty modifications of their favourite celebrities through social media channels, which magnify this influence. Nowadays, a lot of people want to look like celebrities, asking for particular traits that match the style that these giants have made popular. Not just women are following this trend; male celebrities are also changing how people view beauty and masculinity, which increases the market's attractiveness. 'Additionally, as filler debates gain traction, specialists are addressing worries regarding safety and natural outcomes, which reassures prospective customers even more. Celebrity endorsements and growing consumer awareness are driving India's dermal fillers business, increasing accessibility and acceptance of aesthetic modifications across a range of demographics.

Future Market Scenario (FY2025 - FY2032F)

The dermal filler market is set to grow because of new developments in technology, life sciences, and materials research. There is a rising need for non-invasive treatments, that will boost innovation.

Furthermore, technological advancements like AI integration in laser devices are changing the field by improving image analysis and making research processes faster, which greatly supports market growth. Other than this, innovations are the supporting pillars of this ever-growing market. For instance, the Profhilo injectable therapy is a novel cosmetic procedure that has swept the beauty industry in India off its feet. Often referred to as the "injectable moisturizer," this treatment has grown in favor among those who want to look younger, more radiant, and refreshed without undergoing invasive treatments. Profhilo adopts a novel strategy by hydrating the skin from the inside out, in contrast to conventional dermal fillers, which seek to reduce wrinkles and increase volume.

Key Players Landscape and Outlook

Key players in the dermal fillers industry are utilizing strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing big-cap industry players to increase their presence and, therefore, find new opportunities in this market.

For instance, in October 2023, A. Menarini India Private Limited (often called "Menarini India"), a part of the Menarini Group, the biggest Italian biopharmaceutical company in the world and a pioneer in dermatological and cosmetics treatments, announced its entry into the Indian aesthetics market. Through a combination of specialized, well-made products and procedures, Menarini and RELIFE, which have their main offices in Italy, provide aesthetic physicians and surgeons with a holistic approach to cosmetic medicine to assist patients in attaining effortlessly beautiful skin.

For instance, in an effort to develop powerful instruments that provide the best outcomes for practitioners and patients, Prollenium Medical Technologies Inc. announced in October 2023 that it has acquired SoftFil medical devices.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. India Dermal Fillers Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product Type
    • 4.2.1.1. Biodegradable
    • 4.2.1.2. Non-Biodegradable
  • 4.2.2. By Application
    • 4.2.2.1. Facial Line Correction
    • 4.2.2.2. Lip Augmentation
    • 4.2.2.3. Face Lift
    • 4.2.2.4. Acne Scar Treatment
    • 4.2.2.5. Others
  • 4.2.3. By Ingredients
    • 4.2.3.1. Hyaluronic Acid
    • 4.2.3.2. Calcium Hydroxylapatite
    • 4.2.3.3. Poly-L-Lactic Acid
    • 4.2.3.4. Others
  • 4.2.4. By End-user
    • 4.2.4.1. Specialty Dermatology Clinics
    • 4.2.4.2. Hospitals and Clinics
    • 4.2.4.3. Others
  • 4.2.5. By Region
    • 4.2.5.1. North
    • 4.2.5.2. South
    • 4.2.5.3. East
    • 4.2.5.4. West and Central
    • 4.2.5.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Product Type
  • 4.3.2. By Application
  • 4.3.3. By Ingredients
  • 4.3.4. By End-user
  • 4.3.5. By Region

All segments will be provided for all regions and countries covered

5. Demand Supply Analysis

6. Value Chain Analysis

7. Porter's Five Forces Analysis

8. PESTLE Analysis

9. Pricing Analysis

10. Market Dynamics

• 10.1. Market Drivers
• 10.2. Market Challenges

11. Market Trends and Developments

12. Regulatory Framework and Innovation

• 12.1. Clinical Trials (Global)
• 12.2. Regulatory Approvals

13. Patent Landscape

14. Case Studies

15. Competitive Landscape

• 15.1. Competition Matrix of Top 5 Market Leaders
• 15.2. SWOT Analysis for Top 5 Players
• 15.3. Key Players Landscape for Top 10 Market Players
  • 15.3.1. Galderma SA
    • 15.3.1.1. Company Details
    • 15.3.1.2. Key Management Personnel
    • 15.3.1.3. Products and Services
    • 15.3.1.4. Financials (As Reported)
    • 15.3.1.5. Key Market Focus and Geographical Presence
    • 15.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 15.3.2. Bioplus Co., Ltd.
  • 15.3.3. Prollenium Medical Technologies Inc.
  • 15.3.4. BIOXIS Pharmaceuticals SAS
  • 15.3.5. Sinclair, Inc.
  • 15.3.6. Allergan Aesthetics plc (AbbVie Inc.)
  • 15.3.7. Dr. Korman Laboratories Ltd.
  • 15.3.8. Zhejiang Jingjia Medical Technology Co., Ltd.
  • 15.3.9. Medytox Inc.
  • 15.3.10. SciVision Biotech Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

16. Strategic Recommendations

17. About Us and Disclaimer